© 2020 MJH Life Sciences and Cure Today. All rights reserved.
© 2020 MJH Life Sciences™ and Cure Today. All rights reserved.
August 13th 2020, 4:00am
After a cancer diagnosis, Maryland Governor Larry Hogan had to lean on family from both his personal and professional life to helping take on treatment and beat cancer twice.
August 12th 2020, 4:00am
“These results further support our efforts to reimagine medicine in this incurable malignancy and reach this underserved patient population, who are historically burdened with several years of various treatments,” said Dr. John Tsai.
August 1st 2020, 5:24am
The Food and Drug Administration approved Monjuvi in combination with Revlimid for the treatment of adult patients with relapsed or refractory diffuse large B-cell lymphoma.
July 30th 2020, 7:00pm
In this week’s episode of the CURE Talks Cancer podcast, Maryland Governor Larry Hogan opens up about what it was like to go through cancer not once but twice, and why he considers every day a gift.
July 24th 2020, 8:00pm
Here, a survivor lists some alternative ways that patients with cancer or survivors in need of flexible employment can earn extra money.
July 18th 2020, 6:00pm
Ethan Zohn, "Survivor: Africa" winner, discusses how his winner’s mentality helped him through treatment and how leaning on others has been key in survivorship.
July 13th 2020, 7:00pm
“Having new options is important, particularly when patients have already been through chemotherapy and some of the other therapies that are available,” said Dr. John P. Leonard.
July 10th 2020, 7:52pm
From a new trial in Canada looking at therapeutics to help prevent severe symptoms of COVID-19 in patients with cancer to updated guidelines from the American Cancer Society on taking the HPV vaccine to prevent certain cancers, here’s what’s making the headlines in the cancer space this week.
June 26th 2020, 1:00am
“Let's try to make something good out of something really bad,” says “Survivor: Africa” winner, and lymphoma survivor, Ethan Zohn.
June 23rd 2020, 11:20pm
The Food and Drug Administration has had a busy couple of weeks, approving new agents to treat a variety of cancers. Here are five recent approvals that patients with cancer may have missed.